Detalhe da pesquisa
1.
Helical Luttinger Liquid on the Edge of a Two-Dimensional Topological Antiferromagnet.
Nano Lett
; 22(18): 7606-7614, 2022 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123350
2.
Strain-Release Heteroatom Functionalization: Development, Scope, and Stereospecificity.
J Am Chem Soc
; 139(8): 3209-3226, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28140573
3.
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in underdoped Bi2Sr2CaCu2O8+δ.
Natl Sci Rev
; 11(5): nwad249, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577674
4.
Fabrication-induced even-odd discrepancy of magnetotransport in few-layer MnBi2Te4.
Nat Commun
; 15(1): 3399, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649376
5.
Design and Synthesis of Functionally Active 5-Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1.
J Med Chem
; 66(7): 4888-4909, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940470
6.
Direct visualization of edge state in even-layer MnBi2Te4 at zero magnetic field.
Nat Commun
; 13(1): 7714, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513662
7.
Development of a Late-Stage Diversification Strategy for the 4- and 5-Positions of 4,5,6-Trisubstituted Indazoles.
Org Lett
; 22(22): 9047-9052, 2020 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33166447
8.
2-Morpholino-4-oxo-4,5-dihydro-thio-phene-3-carbonitrile.
Acta Crystallogr Sect E Struct Rep Online
; 65(Pt 11): o2765, 2009 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21578359
9.
Effects of SI and PCV on respiratory mechanics, early central drive and hemodynamics in patients with ARDS.
Exp Ther Med
; 17(4): 2708-2714, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30906461
10.
Rhodium(III)-Catalyzed C-H Activation: Ligand-Controlled Regioselective Synthesis of 4-Methyl-Substituted Dihydroisoquinolones.
Org Lett
; 21(14): 5689-5693, 2019 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31264873
11.
Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497).
J Med Chem
; 61(3): 650-665, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211475
12.
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors.
J Med Chem
; 50(22): 5253-6, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17887663
13.
Organic chemistry. Strain-release amination.
Science
; 351(6270): 241-6, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26816372
14.
Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216.
Clin Cancer Res
; 20(3): 631-43, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240111
15.
Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations.
J Med Chem
; 57(11): 4720-44, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24819116
16.
Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib.
J Med Chem
; 57(4): 1170-87, 2014 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24432909
17.
Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design.
ACS Med Chem Lett
; 4(1): 91-7, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24900568
18.
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity.
ACS Med Chem Lett
; 2(11): 809-13, 2011 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24900269
19.
Mosquito nets impregnated with deltamethrin against malaria vectors in China / by Li Zuzi ...[et al.]
Geneva; World Health Organization; 1987. (WHO/VBC/87.939. Unpublished).
em Inglês
| WHOLIS | ID: who-62408